AI English summary of an SEC filing — figures as filed
Charles River Laboratories CRLThe company said revenue for Q1 2025 was $984.2 million, a decrease of 2.7% from $1,011.6 million in Q1 2024. Foreign exchange translation reduced reported revenue by 0.9%. Excluding that impact, organic revenue decreased 1.8%, with declines in all three segments.
Key points
AI summaryThe company said revenue for Q1 2025 was $984.2 million, a decrease of 2.7% from $1,011.6 million in Q1 2024. Foreign exchange translation reduced reported revenue by 0.9%. Excluding that impact, organic revenue decreased 1.8%, with declines in all three segments.
Charles River said its GAAP operating margin for Q1 2025 decreased to 7.6% from 12.5%. It cited lower revenue and higher amortization from the accelerated amortization of certain CDMO client relationships as the main factors. Its non-GAAP operating margin increased to 19.1% from 18.5%.
Charles River said GAAP net income available to common shareholders for Q1 2025 was $25.5 million ($0.50 per share), down from net income of $67.3 million ($1.30 per diluted share) in the same period a year earlier. Non-GAAP diluted earnings per share rose 3.1% to $2.34 from $2.27.
The company said it repurchased 2.1 million shares in Q1 2025 for a total of $350.0 million. It said $549.3 million remained under its $1.0 billion repurchase authorization as of March 29, 2025. The company also raised its non-GAAP EPS outlook for 2025 to $9.30 – $9.80 from the prior $9.10 – $9.60.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q1 2025 Revenue Down $984.2 million, Organic Down 1.8%
The company said revenue for Q1 2025 was $984.2 million, a decrease of 2.7% from $1,011.6 million in Q1 2024. Foreign exchange translation reduced reported revenue by 0.9%. Excluding that impact, organic revenue decreased 1.8%, with declines in all three segments.
Source · Based on the filing body and exhibits
GAAP Operating Margin 7.6%, Non-GAAP Operating Margin 19.1%
Charles River said its GAAP operating margin for Q1 2025 decreased to 7.6% from 12.5%. It cited lower revenue and higher amortization from the accelerated amortization of certain CDMO client relationships as the main factors. Its non-GAAP operating margin increased to 19.1% from 18.5%.
Source · Based on the filing body and exhibits
GAAP EPS $0.50, Non-GAAP Diluted EPS $2.34
Charles River said GAAP net income available to common shareholders for Q1 2025 was $25.5 million ($0.50 per share), down from net income of $67.3 million ($1.30 per diluted share) in the same period a year earlier. Non-GAAP diluted earnings per share rose 3.1% to $2.34 from $2.27.
Source · Based on the filing body and exhibits
Charles River Buys Back $350.0 million of Stock in Q1 2025, Raises Non-GAAP EPS Outlook
The company said it repurchased 2.1 million shares in Q1 2025 for a total of $350.0 million. It said $549.3 million remained under its $1.0 billion repurchase authorization as of March 29, 2025. The company also raised its non-GAAP EPS outlook for 2025 to $9.30 – $9.80 from the prior $9.10 – $9.60.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…